In such a case, the payment limit based on the ASPs of competitor biosimilars would be higher than if we were constrained to use ASP data only from the biosimilar that has most recently reported negative or zero manufacturer's ASP data
Durable, portable, and ready to haunt your pocket, its perfect for quick hits when youre on the move
People dont exactly want to affiliate themselves with someone with a bad reputation, for good reason
If the player speeds in Satsuma with Susuki, Susuki tells him not to do Yani, but Susuki calls Yani a beast
In contrast, our approach is not based on a therapeutic index, which is not necessarily associated with risk, but uses the most recent guidelines for risk assessment of chemical substances, which also takes the population-based exposure into account